Apex Receives Non-Compliance Letter from NYSE Alternext US

London Stock Exchange
Advanced charts
Premium community
Data download

Name	Symbol	Market	Type
ProShares Global Listed Private Equity	AMEX:PEX	AMEX	Exchange Traded Fund

Name

Symbol

Market

Type

ProShares Global Listed Private Equity

AMEX:PEX

AMEX

Exchange Traded Fund

	Price Change	% Change	Price	High Price	Low Price	Open Price	Traded	Last Trade
	0.1666	0.58%	28.835	28.88	28.76	28.86	1,537	21:15:00

Price Change

% Change

Price

High Price

Low Price

Open Price

Traded

Last Trade

0.1666

0.58%

28.835

28.88

28.76

28.86

1,537

21:15:00

Apex Receives Non-Compliance Letter from NYSE Alternext US

13/02/2009 8:02pm

PR Newswire (US)

ProShares Global Listed ... (AMEX:PEX)
Historical Stock Chart

From Nov 2019 to Nov 2024

Click Here for more ProShares Global Listed ... Charts.

HILLSBOROUGH, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Alternext US: PEX) announced today that it has received notice from NYSE Alternext US LLC (the "Exchange") that the Company is not in compliance with Section 704 of the Exchange's Company Guide because the Company did not hold an annual meeting during the calendar year 2008. In order to maintain its listing on the Exchange, the Company intends to submit a plan by March 10, 2009 addressing how it intends to regain compliance by August 11, 2009. If the Company does not submit a plan or if this plan is not accepted by the Exchange, the Company will be subject to delisting procedures. Forward-Looking Statements This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements are based on current expectations and are subject to numerous risks, assumptions and uncertainties, many of which change over time and are beyond Apex's control. Actual results may differ materially from those anticipated in any forward-looking statement and you should not place any undue reliance on such forward-looking statements. More detailed information about Apex and risk factors that may affect the realization of forward-looking statements, including forward-looking statements in this press release, is set forth in Apex's filings with the Securities and Exchange Commission. Apex urges investors and security holders to read those documents free of charge at the Commission's web site at http://www.sec.gov/. Interested parties may also obtain these documents free of charge from Apex. Forward-looking statements speak only as to the date they are made, and except for any obligation under the U.S. federal securities laws, Apex undertakes no obligation to publicly update any forward-looking statement as a result of new information, future events or otherwise. DATASOURCE: Apex Bioventures Acquisition Corporation CONTACT: Darrell J. Elliott, Chairman and Chief Executive Officer, +1-604-924-0349, or K. Michael Forrest, President and Chief Operating Officer, +1-650-344-3029, both of Apex Bioventures Acquisition Corporation

	Real-time Prices	Level 2
London Stock Exchange
Chi-X Europe
BATS Europe
Aquis Exchange
FTSE Indices
Euronext
New York Stock Exchange
NASDAQ
American Stock Exchange
Dow Jones Indices
Forex
Precious Metal

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

PEX ProShares Global Listed Private Equity